Clinical Trial Update: Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating the combination of the immune modulator dimethyl fumarate with alteplase for acute ischemic stroke (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)
• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Acute Ischemic Stroke | Phase 1, Phase 2 | Status: UNKNOWN